Home > Products > BAFF & IL17
> Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scFv-CH1/CL)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-019)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-BAFF antibody variable domain is fused to CH1 and the other scFv from an anti-IL17 antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can neutralize both BAFF and IL- 17 simultaneously. It is designed for the research of Lupus Nephritis (LN); Systemic Lupus Erythematosus (SLE); Rheumatoid Arthritis (RA); Psoriasis (Ps); Ankylosing Spondylitis (AS); Psoriatic Arthritis (PA) primary Sjögren's Syndrome (pSS); Multiple Myeloma (MM) therapy.
There are currently no customer reviews or questions for Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scFv-CH1/CL) (BSCC-019). Click the button below to contact us or submit your feedback about this product.